Glucagon-Like Peptide 1 Receptor Agonists Are Not Associated With an Increased Risk of Ileus or Intestinal Obstruction in Patients with Inflammatory Bowel Disease—A Danish Nationwide Cohort Study
Inflammatory Bowel Diseases · 07.07.2025 · 31 (7) · 1961-1965
DOI: 10.1093/ibd/izae276 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 27.11.2024. Verfasst von Jan Nielsen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Ileus, Glucagon-Like Peptide-1 Receptor Agonists, Inflammatory Bowel Diseases, Intestinal Obstruction. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
There is a global increase in the prevalence of obesity, including among individuals with inflammatory bowel disease (IBD). Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are potential anti-obesity medications due to their weight-lowering effects. However, concerns exist regarding ileus and intestinal obstruction as a severe side effect.
Methods
This nationwide Danish cohort study evaluates the risk of ileus and intestinal obstruction in patients with IBD receiving GLP-1RAs. Patients with IBD and their exposure to GLP-1RAs were identified using Danish health registries. Cox regression analysis was used to estimate hazard ratios for the risk of ileus and intestinal obstruction adjusted for age at diagnosis of IBD, sex, type of IBD, prior ileus or intestinal obstruction, diabetes status, steroid use, and small bowel or colon surgery.
Results
This study found that GLP-1RA exposure was not associated with an increased risk of ileus or intestinal obstruction in patients with IBD.
Conclusion
This study suggests that GLP-1RAs do not increase the risk of ileus or intestinal obstruction in patients with IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark.
- Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Gastroenterology Division, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA.
- Department of Medical Gastroenterology, Hospital of South West Jutland, Denmark.
- Department of Regional Health Research, University of Southern Denmark, Denmark.
- Department of Medical Gastrointestinal Diseases, Odense University Hospital, Odense, Denmark.
ORCID-Profile: Jan Nielsen, Sonia Friedman, Bente Mertz Nørgård, Torben Knudsen, Jens Kjeldsen, Mette Wod
Zitieren
APA
Nielsen, J., Friedman, S., Nørgård, B. M., Knudsen, T., Kjeldsen, J., & Wod, M. (2025). Glucagon-Like Peptide 1 Receptor Agonists Are Not Associated With an Increased Risk of Ileus or Intestinal Obstruction in Patients with Inflammatory Bowel Disease—A Danish Nationwide Cohort Study. Inflammatory Bowel Diseases, 31(7), 1961-1965. https://doi.org/10.1093/ibd/izae276
Vancouver
Nielsen J, Friedman S, Nørgård BM, Knudsen T, Kjeldsen J, Wod M. Glucagon-Like Peptide 1 Receptor Agonists Are Not Associated With an Increased Risk of Ileus or Intestinal Obstruction in Patients with Inflammatory Bowel Disease—A Danish Nationwide Cohort Study. Inflammatory Bowel Diseases. 2025;31(7):1961-1965. doi:10.1093/ibd/izae276
BibTeX
@article{Nielsen2025,
author = {Nielsen, Jan and Friedman, Sonia and Nørgård, Bente Mertz and Knudsen, Torben and Kjeldsen, Jens and Wod, Mette},
title = {Glucagon-Like Peptide 1 Receptor Agonists Are Not Associated With an Increased Risk of Ileus or Intestinal Obstruction in Patients with Inflammatory Bowel Disease—A Danish Nationwide Cohort Study},
journal = {Inflammatory Bowel Diseases},
year = {2025},
volume = {31},
number = {7},
pages = {1961--1965},
doi = {10.1093/ibd/izae276}
}
EUVIMED